Group 1 - The core viewpoint of the news is the performance and holdings of the Fuqua Precision Medical Mixed A fund, which has shown significant growth in recent months and has a strong portfolio in the healthcare sector [1][3] - As of August 6, 2025, the latest net value of the Fuqua Precision Medical Mixed A fund is 3.6555 yuan, reflecting a growth of 1.42% [1] - The fund's performance over the past month has yielded a return of 11.37%, ranking 428 out of 2330 in its category, while its six-month return stands at 66.82%, ranking 12 out of 2302 [1] - Year-to-date, the fund has achieved a return of 64.05%, ranking 13 out of 2291 in its category [1] Group 2 - The top ten stock holdings of the Fuqua Precision Medical Mixed A fund account for a total of 70.14%, with significant positions in companies such as Huatai Medical (9.23%), Haisco (8.62%), and Baillie Tianheng (8.62%) [1] - The fund was established on November 16, 2017, and as of June 30, 2025, it has a total asset size of 3.645 billion yuan [1] - The fund manager, Zhao Wei, has extensive experience in the pharmaceutical and investment sectors, having held various positions in companies such as GlaxoSmithKline and China Merchants Fund Management [2]
8月6日富国精准医疗混合A净值增长1.42%,近6个月累计上涨66.82%
Sou Hu Cai Jing·2025-08-06 12:13